Jim Kuo

Dr. Kuo has over 25 years of experience in senior leadership roles in pharmaceutical business development. He has played key roles in leading venture capital financing, strategic partnerships, licensing and strategic planning in the genomics, small molecule, biotherapy, monoclonal antibody and inflammatory disease. He is currently the Chairman of the Board of Immunoprecise Antibodies and Monarch Labs.